—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Revolution Medicines Inc (RVMD) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 26 out of 100 (momentum 78 · quality 2 · valuation 6), as of 2026-11-11.
  • Signal: Pullback inside an uptrend stack — Trades -1.7% vs the 50-day and +21.6% vs the 200-day average, 13.9% below the 52-week high and +213.9% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: Revolution Medicines Inc trades 1.7% below its 50-day and 21.6% above its 200-day moving average. (as of 2026-11-10)

Revolution Medicines is a clinical-stage biotechnology company that designs drugs for cancers driven by mutated RAS proteins. Its lead candidate, daraxonrasib, sits in a late-stage trial for first-line pancreatic cancer alongside a second RAS-targeting compound, zoldonrasib.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the RVMD overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pullback inside an uptrend stack

Trades -1.7% vs the 50-day and +21.6% vs the 200-day average, 13.9% below the 52-week high and +213.9% off the 52-week low. Computed from daily closes.

Ranked #41 on today’s Directional Flow — Top scores list (scan of 2026-11-10).

The moving-average stack

Continue: the RVMD chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on RVMD?

Pullback inside an uptrend stack — Trades -1.7% vs the 50-day and +21.6% vs the 200-day average, 13.9% below the 52-week high and +213.9% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is RVMD above its 50-day and 200-day moving averages?

As of 2026-11-10, Revolution Medicines Inc trades -1.7% below its 50-day and +21.6% above its 200-day average, with the 20-day +1.8% away.

How far is RVMD from its 52-week high?

13.9% below the 52-week high and 213.9% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.